Takeshi Shimamura
Overview
Explore the profile of Takeshi Shimamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
6050
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luan Q, Pulido I, Isagirre A, Carretero J, Zhou J, Shimamura T, et al.
Lab Chip
. 2024 Feb;
24(7):2025-2038.
PMID: 38410967
Patient-derived organoids (PDOs) serve as invaluable 3D tumor models, retaining the histological complexity and genetic heterogeneity found in primary tumors. However, the limitation of small sample volumes and the lack...
2.
Shimamura T, Ishikawa H, Fujii H, Katoh H
J Phys Ther Sci
. 2023 Dec;
35(12):796-801.
PMID: 38075512
[Purpose] This study aimed to investigate the usefulness of a quality index in gait for proximal femur fractures. [Participants and Methods] In this study, 20 females with postoperative proximal femur...
3.
Shimamura T, Ishikawa H, Fujii H, Katoh H
Geriatrics (Basel)
. 2023 Oct;
8(5).
PMID: 37887971
Background: Studies that quantify the quality of sit-to-stand-to-sit (STS) motions, particularly in terms of smoothness, are limited. Thus, this study aimed to investigate the possibility and usefulness of quality evaluation...
4.
Deng J, Peng D, Fenyo D, Yuan H, Lopez A, Levin D, et al.
bioRxiv
. 2023 May;
PMID: 37131623
Significance: Loss-of-function mutations in the tumor suppressor of lung adenocarcinoma patients and are associated with resistance to current treatments. Our study identified CD38 as a potential therapeutic target that is...
5.
Jusue-Torres I, Tiv R, Ricarte-Filho J, Mallisetty A, Contreras-Vargas L, Godoy-Calderon M, et al.
Sci Rep
. 2023 Mar;
13(1):4107.
PMID: 36914720
This study aims to perform a comprehensive genomic analysis to assess the influence of overexpression of MYO1E in non-small cell lung carcinoma (NSCLC) and whether there are differences in survival...
6.
Luan Q, Becker J, Macaraniag C, Massad M, Zhou J, Shimamura T, et al.
Lab Chip
. 2022 May;
22(12):2364-2375.
PMID: 35551303
There is a growing interest in developing personalized treatment strategies for each cancer patient, especially those with non-small cell lung carcinoma (NSCLC) which annually accounts for the majority of cancer...
7.
Kobayashi N, Wild D, Kaul F, Shimamura T, Takano S, Takeda Y, et al.
J Hepatobiliary Pancreat Sci
. 2021 Jun;
28(9):727-739.
PMID: 34174175
Background: Peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs is an innovative treatment for advanced somatostatin-positive neuroendocrine tumors (NETs). PRRT cannot be performed in Japan because there is no...
8.
Shimamura T, Katoh H
J Phys Ther Sci
. 2021 Apr;
33(3):246-249.
PMID: 33814712
[Purpose] To quantitatively evaluate smoothness during standing and sitting motion analysis using an accelerometer and to clarify the relationship between indices. [Participants and Methods] Seventeen healthy males participated in this...
9.
Pulido I, Ollosi S, Aparisi S, Becker J, Aliena-Valero A, Benet M, et al.
Cancer Res
. 2020 Aug;
80(19):4224-4232.
PMID: 32747363
Progression on therapy in non-small cell lung carcinoma (NSCLC) is often evaluated radiographically, however, image-based evaluation of said therapies may not distinguish disease progression due to intrinsic tumor drug resistance...
10.
Fujisawa T, Shimamura T, Goto K, Nakagawa R, Muroyama R, Ino Y, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32443847
Perineural invasion (PNI) is one of the major pathological characteristics of pancreatic ductal adeno-carcinoma (PDAC), which is mediated by invading cancer cells into nerve cells. Herein, we identify the overexpression...